Patient factors associated with receiving reversal therapy in oral anticoagulant-related intracerebral hemorrhage.

Apostolaki-Hansson, Trine; Ullberg, Teresa; Norrving, Bo; Petersson, Jesper

Apostolaki-Hansson, Trine; Ullberg, Teresa; Norrving, Bo; Petersson, Jesper.

Afiliación

Apostolaki-Hansson T; Department of Neurology, Lund University, Skåne University Hospital, Lund, Sweden.
Ullberg T; Department of Neurology, Lund University, Skåne University Hospital, Lund, Sweden.
Norrving B; Department of Neurology, Lund University, Skåne University Hospital, Lund, Sweden.
Petersson J; Department of Neurology, Lund University, Skåne University Hospital, Lund, Sweden.

Acta Neurol Scand ; 146(5): 590-597, 2022 Nov.

Article en En | MEDLINE | ID: mdl-35974708

Asunto(s)

Hemostáticos; Accidente Cerebrovascular; Administración Oral; Anticoagulantes/efectos adversos; Hemorragia Cerebral/inducido químicamente; Hemorragia Cerebral/complicaciones; Fibrinolíticos/uso terapéutico; Hemostáticos/uso terapéutico; Humanos; Accidente Cerebrovascular/complicaciones; Accidente Cerebrovascular/tratamiento farmacológico

Palabras clave

intracerebral hemorrhage; non-vitamin K oral anticoagulant; oral anticoagulant drug; reversal therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemostáticos / Accidente Cerebrovascular Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Acta Neurol Scand Año: 2022 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google